← back to search

Giel Nijpels

Amsterdam Neuroscience · NL
Area of research
Endocrinology, Diabetes and Metabolism · Epidemiology
Research interest
Research interests include Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Management and Education, Chronic Disease Management Strategies, and Diabetes Treatment and Management.
h-index
86
citations
34,031
works
593
NIH funding
primary concept
email

Recent publications

Type 2 Diabetes, the Epidemic: Trends in Prevalence and Incidence, 2004-2020.
2024cited by 11position: contributordoi
Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models
Nature Biotechnology 2023cited by 104position: middledoi
Cost-Effectiveness of SGLT2 Inhibitors in a Real-World Population: A MICADO Model-Based Analysis Using Routine Data from a GP Registry
PharmacoEconomics 2023cited by 14position: middledoi
Cost-Effectiveness of SGLT2 Inhibitors in a Real-World Population: A MICADO Model-Based Analysis Using Routine Data from a GP Registry.
2023cited by 9position: contributordoi
Identification of frailty in primary care: accuracy of electronically derived measures.
2023cited by 4position: contributordoi
Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction.
2022cited by 21position: contributordoi
"I am my own doctor": A qualitative study of the perspectives and decision-making process of Muslims with diabetes on Ramadan fasting.
2022cited by 12position: contributordoi
Safety risks among frail older people living at home in the Netherlands - A cross-sectional study in a routine primary care sample.
2022cited by 5position: contributordoi
The DIAbetes MANagement and Treatment (DIAMANT) Cohort.
2022cited by 3position: contributordoi
Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study
BMJ 2021cited by 67position: middledoi
Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study.
2021cited by 47position: contributordoi
Plasma protein <i>N-</i>glycosylation is associated with cardiovascular disease, nephropathy, and retinopathy in type 2 diabetes.
2021cited by 28position: contributordoi
Prognostic models for predicting the risk of foot ulcer or amputation in people with type 2 diabetes: a systematic review and external validation study.
2021cited by 20position: contributordoi
Prevalence of ECG abnormalities in people with type 2 diabetes: The Hoorn Diabetes Care System cohort.
2021cited by 16position: contributordoi
Validation of a model for the prediction of retinopathy in persons with type 1 diabetes.
2021cited by 13position: contributordoi
The interobserver agreement of ECG abnormalities using Minnesota codes in people with type 2 diabetes.
2021cited by 6position: contributordoi
Discovery of predictors of sudden cardiac arrest in diabetes: rationale and outline of the RESCUED (REcognition of Sudden Cardiac arrest vUlnErability in Diabetes) project.
2021cited by 4position: contributordoi
Clinical profiles of post-load glucose subgroups and their association with glycaemic traits over time: An IMI-DIRECT study.
2021cited by 1position: contributordoi
Gamma-glutamyltransferase, arterial remodeling and prehypertension in a healthy population at low cardiometabolic risk.
2021cited by 1position: contributordoi
A reference map of potential determinants for the human serum metabolome
Nature 2020cited by 443position: middledoi
A reference map of potential determinants for the human serum metabolome
Nature 2020cited by 413position: contributordoi
Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial
The Lancet Diabetes & Endocrinology 2020cited by 251position: middledoi
Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial.
2020cited by 189position: contributordoi
Prediction models for development of retinopathy in people with type 2 diabetes: systematic review and external validation in a Dutch primary care setting
Diabetologia 2020cited by 42position: middledoi
Plasma Metabolomics Identifies Markers of Impaired Renal Function: A Meta-analysis of 3089 Persons with Type 2 Diabetes.
2020cited by 33position: contributordoi
Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction
Heart Failure Reviews 2020cited by 32position: middledoi
Prediction models for development of retinopathy in people with type 2 diabetes: systematic review and external validation in a Dutch primary care setting.
2020cited by 31position: contributordoi
Cardiovascular Event Risk in Rheumatoid Arthritis Compared with Type 2 Diabetes: A 15-year Longitudinal Study.
2020cited by 27position: contributordoi
Improving Person-Centredness in Integrated Care for Older People: Experiences from Thirteen Integrated Care Sites in Europe.
2020cited by 24position: contributordoi
Addressing safety risks in integrated care programs for older people living at home: a scoping review.
2020cited by 18position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Petra M. Elders · Catharina Ziekenhuis21 papers (2019–2024)Joline W J Beulens · Oklahoma State University Center for Health Sciences16 papers (2019–2023)Leen M. ‘t Hart · University of Gothenburg8 papers (2019–2021)Joline W. J. Beulens · Oklahoma State University Center for Health Sciences5 papers (2018–2023)Petra J. M. Elders · Amsterdam Neuroscience5 papers (2015–2023)Ron M. C. Herings · Amsterdam UMC Location Vrije Universiteit Amsterdam4 papers (2021–2024)Roderick C. Slieker · GGD Amsterdam4 papers (2019–2021)Jeroen Lakerveld · Utrecht University4 papers (2012–2018)Marieke T. Blom · Amsterdam Neuroscience4 papers (2021–2024)Ilse De Bourdeaudhuij · Ghent University Hospital3 papers (2012–2018)Coen D.A. Stehouwer · UCLouvain3 papers (2020–2020) · 3 papers (2021–2023)Amber A. van der Heijden · Amsterdam University Medical Centers3 papers (2019–2023)Joline W. J. Beulens · Amsterdam UMC Location Vrije Universiteit Amsterdam3 papers (2020–2021)Karin M.A. Swart · University of Eastern Finland3 papers (2022–2024)Talitha Feenstra · National Institute for Public Health and the Environment3 papers (2020–2023)Harry Rutter · London School of Hygiene & Tropical Medicine3 papers (2012–2018)Joost Dekker · Princess Máxima Center2 papers (2012–2013)Amber A. van der Heijden · National Institute for Public Health and the Environment2 papers (2020–2021)Jean‐Michel Oppert · Conservatoire National des Arts et Métiers2 papers (2012–2014)